Search Results 51-60 of 17824 for Hepatitis C

  1. A Study of the Frequency of Hepatitis B, Hepatitis C, and Hepatocellular Carcinoma Among Minnesota's African Immigrants, and Their Knowledge of the Diseases. - Mayo Clinic

    The purpose of this study is to find the rate of Hepatitis B, Hepatitis C, and Hepatocellular Carcinoma in individual populations of African descendants living ...

  2. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  3. Hepatitis A - Symptoms and causes - Mayo Clinic

    Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. ... People with chronic liver disease, including hepatitis B or hepatitis C ...

  4. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...

  5. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  6. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus ...

  7. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Age ≥ 18 years · Previously undergone orthotopic liver transplant (OLT) at least 2 months prior to the planned start of dosing · Aggressive Hepatitis C infection ...

  8. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...

  9. cirrhosis Archives - Mayo Clinic News Network

    from hepatitis C, antiviral treatment is recommended for everyone diagnosed with the virus. The antiviral medication used to fight hepatitis C is effective in ...

  10. Hepatitis C - Doctors and departments - Mayo Clinic

    Immunologists and virologists also are working on making a hepatitis C vaccine. Another area of research is cell transplant. This involves putting liver cells, ...